Gene Mutation Linked to Microcephaly Offers New Insights into Brain Development
A groundbreaking study published on October 24, 2025, has identified a previously unknown genetic cause of primary microcephaly, a congenital condition characterized by significantly reduced brain size and often accompanied by developmental delays. Researchers pinpointed mutations in the EXOSC10 gene as a key factor, opening new avenues for understanding and potentially treating this complex neurodevelopmental disorder.
Understanding Microcephaly and Brain Development
Microcephaly impacts brain development by disrupting the delicate balance between neural stem cell self-renewal and differentiation – the processes by which these cells multiply and specialize to form the cerebral cortex, the brain’s outer layer responsible for higher-level cognitive functions. Disturbances in this balance can lead to malformations and impaired neurological development. Recent advancements in genome sequencing and genetic engineering are rapidly accelerating our understanding of these intricate processes.
Identifying the EXOSC10 Gene
An international research team, led by Dr. Tran Tuoc of the Department of Human Genetics at Ruhr University Bochum in Germany, identified de novo EXOSC10 mutations in patients exhibiting microcephaly and cortical malformations through comprehensive genomic screening. To investigate the impact of these mutations, the team developed specialized mouse models that replicated the human genetic changes.
“This reduced the stem cell population, and the cerebral cortex remained smaller – closely mirroring the patients’ phenotype,” explained Dr. Pauline Ulmke, the study’s first author. The research revealed that a partial loss of EXOSC10 function in the developing mouse brain led to premature differentiation of neural stem cells into neurons, effectively diminishing the pool of progenitor cells available for brain growth.
The Role of RNA and the Sonic Hedgehog Pathway
Further investigation using RNA sequencing and RNA immunoprecipitation analyses uncovered a critical link between EXOSC10 and the Sonic hedgehog (Shh) signaling pathway. The researchers found that EXOSC10 normally regulates the degradation of key transcripts within this pathway, specifically Scube1 and Scube3. When EXOSC10 function was compromised, these transcripts accumulated, resulting in abnormally high Shh activity.
Remarkably, reducing Shh signaling in the mutant mice partially restored normal cortical size. “Notably, reducing Shh signalling in mutant mice largely rescued cortical size, pinpointing excessive Shh activity as the main driver of microcephaly in this context,” Ulmke concluded.
A New Understanding of RNA Regulation
“Our study uncovers a previously unknown link between RNA decay and Sonic hedgehog signalling in brain development,” Dr. Tuoc stated. “It shows that a delicate balance of RNA degradation is essential to maintain proper growth of the cerebral cortex.” The findings demonstrate that post-transcriptional RNA regulation plays a crucial role in controlling progenitor dynamics and ultimately, brain size.
This research not only expands the genetic landscape of primary microcephaly but also provides valuable mechanistic insights into the complex interplay between RNA metabolism and signaling pathways in human brain malformations. The study underscores the power of cutting-edge sequencing technologies and genetically engineered animal models in unraveling the molecular basis of complex neurodevelopmental disorders. .
The work was supported by funding from the German Research Foundation (TU432/3, TU432/6, GRK2862/1) and medical research funding (F1008N-20, IF-027N-22). The full study, titled “EXOSC10 haploinsufficiency causes primary microcephaly by derepression of Sonic hedgehog signalling,” is available in the journal Brain (doi.org/10.1093/brain/awaf405).
